suPARnostic® ELISA

The CE/IVD marked suPARnostic® ELISA assay is a full quantifiable method.

The suPARnostic® ELISA assay is based on a simplified double monoclonal antibody sandwich ELISA assay whereby samples and peroxidase-conjugated anti-suPAR are first mixed and then incubated in anti-suPAR precoated microwells.

The recombinant suPAR standards of the kit are calibrated against healthy human blood donor samples. The suPAR concentrations are determined as ng/mL plasma.

Clinical benefits of ELISA suPARnostic®:

  • Identification of patients who can be safely discharged after treatment
  • Helps to prioritize patients and reduce Emergency Department crowding
  • Add to clinical decisions
  • Identification of high-risk patients with unaffected vital signs


The suPARnostic® AUTO Flex ELISA kit is CE-IVD certified. It provides fully quantitative results in less than 1½ hours. The kit contains easy-to-use reagents and is flexible with 12×8 strips where up to 91 single samples can be measured on one plate.

Product contains

  • A 96 white Microtiter Plate with 96 wells
  • A pre-coated anti-suPAR 96 wells Microtiter Plate with break-apart wells
  • Standards
  • A Curve Control
  • Peroxidase conjugate
  • Dilution Buffer
  • TMB Solution
  • Wash Buffer
  • Stop Solution
  • Sealing Tape
  • Empty Plastic Bottle


  • Addition of prognostic information to current triaging procedures
  • Aid for prioritizing patients with unclear signs and history
  • Simple to perform
  • Easy to implement at the laboratory
  • Well documented with more than 700 publications

Product Code

Product no. E001: suPARnostic® AUTO Flex ELISA kit for 41-91 tests

Price Quote

Contact us at


See technical documents

Want to buy suPARnostic®?


published suPAR studies in leading medical journals

Nature Medicine Logo
Science Journal Logo
JAMA Pediatrics Logo

The suPARnostic® brand consists of 4 products:

Quick Triage

A Point of Care Solution


For Automated Systems


Clinical and Research

suPARnostic POC+


Point-of-care finger prick

suPAR is used in clinical routine in 48 hospitals

48 hospitals use suPAR in clinical routine for triage of patients in the Emergency Departments and COVID-19 units. Clinical routine is defined by the placement of two Purchasing Orders within the last 12 months rolling.
This period covers January 1, 2022, until December 31, 2022. Some hospital locations cannot be disclosed due to confidentiality.

New Webinar


Catch COVID-19

-Improve your triage

Sign up to view webinar recording

View recording

suPARnostic® by ViroGates